![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
October 17, 2025
Summaries of two clinical trials presented at the 2025 World Conference on Lung Cancer
October 17, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
September 19, 2025
An update on the cancer research environment, a recap of the September NCAB meeting, and a preview of the fall group meeting
August 28, 2025
An open letter from the NCTN Cooperative Group Chairs to Congress on the importance of supporting robust federal funding for cancer research
August 28, 2025
The latest clinical trial findings in breast cancer, leukemia, NCI-MATCH precision medicine, penile cancer, and prostate cancer
July 10, 2025
June 11, 2025
Grant updates; engineering and cancer research; Spring Group Meeting and ASCO highlights
June 11, 2025
The group is recognizing Dr. Schiller for her sustained commitment to mentoring early- and mid-career investigators in cancer medicine
June 11, 2025
The changes broaden eligibility and clarify treatment planning details in this phase 2 trial testing daratumumab-hyaluronidase to eliminate minimal residual disease after initial chemotherapy
June 11, 2025
Researchers with the ECOG-ACRIN Cancer Research Group presented a number of research findings at the 2025 ASCO Annual Meeting
June 11, 2025
Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
April 24, 2025
An update on the Group's activity; a new Central Biorepository and Pathology Facility director; a preview of key Group Meeting sessions